1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Bridge to Artificial Intelligence (Bridge2AI) Program - Stage 2 is an upcoming grant from the NIH Common Fund that will build upon Stage 1 accomplishments to use AI-ready biomedical datasets, tools, and best practices to address major biomedical and behavioral health challenges.
Stage 1 committed $130 million over four years to generate flagship AI-ready datasets and workforce development resources, which are now available through the Bridge2AI portal. Stage 2 will support two initiatives: Innovation Funnels using AI-ready datasets to create tools and insights that improve health outcomes, and a Network for AI Health Science to develop safety measures for responsible AI use in research.
Eligible applicants and award amounts for Stage 2 have not yet been published. The program was approved for a second stage as of January 2026.
Get alerted about grants like this
Get emailed when new opportunities from “NIH Common Fund” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Bridge to Artificial Intelligence (Bridge2AI) | NIH Common Fund Bridge to Artificial Intelligence (Bridge2AI) Bridge to Artificial Intelligence (Bridge2AI) NIH Common Fund’s Bridge to Artificial Intelligence Program (Bridge2AI) The NIH Common Fund’s Bridge to Artificial Intelligence program (Bridge2AI) aims to bridge the gap between biomedical and behavioral research and artificial intelligence (AI).
Learn how this exciting new program will bring together diverse teams to generate tools, resources, and richly detailed AI-ready data that is accurate, reliable, and ethically sourced. The program will also create training materials, best practices, and activities to support workforce development across different research communities.
The NIH Common Fund’s Bridge to Artificial Intelligence (Bridge2AI) program will propel biomedical research forward by setting the stage for widespread adoption of artificial intelligence (AI) that tackles complex biomedical challenges beyond human intuition.
Resources from Bridge2AI Stage I The first stage of the Bridge2AI program tackled a key gap in the biomedical research community by generating new “flagship” data sets and best practices for machine learning (ML) analysis. These datasets were collected and processed with AI modeling in mind.
To complement these datasets, the program also developed: software, standards, tools, best practices and training materials for workforce development. The resources generated by the first stage of the program are available through the Bridge2AI portal .
The second stage of the program will build upon the accomplishments of Stage 1 to use the generated data, tools and best practices to deliver trusted solutions to address major biomedical and behavioral health challenges.
The second stage of Bridge2AI will support two initiatives to propel AI health research: Innovation Funnels – Using AI-ready datasets (including datasets from Bridge2AI Stage 1), the innovation funnels will create tools, devices, and novel insights that use AI to improve health.
Network for AI Health Science - The program will create a network for AI health science that will bring together a network of scientific experts to develop safety measures for responsible AI use and research. This network will also build a framework to inform future AI health sciences research.
Together, the Innovation Funnels and Research Network will generate an ecosystem of research teams that will use AI-enabled tools and solutions to address key health challenges. By improving health and promoting responsible use of AI in medicine, the program aims to build public trust in AI-informed health research and care.
Bridge2AI Approved for 2nd Stage, watch the Jan 2026 Council of Council presentation (starts at 04:03:00) Bridge2AI investigator, Dr. Yael Bensoussan, shares how voice and AI could help detect disease on the Chasing Life podcast Bridge2AI preliminary datasets now available Dr. Chris Kinsinger, Bridge2AI Program Officer, meets with other health care experts at the Health IT Summit to weigh in on AI Learn about the exciting work our researchers are doing.
Team Building & Networking Visit the Bridge2AI Platform (registration required) to hear from NIH leaders, watch videos from the June 2021 Team Building Activities, and join the conversation on Slack . NIH Institute and Center Directors’ Welcome This page last reviewed on
According to the current listing, eligibility includes: Details for Stage 2 funding are not yet published, but institutions that built infrastructure under Stage 1 are well-positioned to compete for continuations. Confirm the full requirements in the official notice before applying.
The current listing shows not yet published (Stage 1 committed $130M over four years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Bridge to Artificial Intelligence (Bridge2AI) Program - Stage 2 (Upcoming) is funded by NIH Common Fund. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
Avoid common NIH grant proposal mistakes including vague specific aims, weak methodology, and poor budget justification that lead to rejection.
Read articleOMB's proposed rewrite of 2 CFR Part 200 would bar political appointees from deferring to peer reviewers and require senior-appointee sign-off on every discretionary grant. NIH new awards are already down about 34% in 2026. Here is what the merit-review changes actually say, how 'Gold Standard Science' becomes a scoring lever, why R1 universities are being written out of some solicitations, and what principal investigators and research offices should do before October 1.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read article